MedTrace Logo

A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy

NCT01248702 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2012-03-07

No results posted yet for this study

Summary

The purpose of this study is to develop and implement a critical pathway to identify patients with ischemic cardiomyopathy who are candidates for an implantable cardioverter-defibrillator (ICD). This study will also determine whether the use of the critical pathway for ICDs is associated with a change in the ICD referral and implantation rate.

Conditions

Interventions

OTHER

Use of the ICD Critical Pathway

The critical pathway is a series of predetermined processes designed to assess a patient's eligibility for an ICD. The critical pathway will incorporate current evidence-based practice guidelines.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • S Cowan, MD, MSc · St. Paul's Hospital, Vancouver, British Columbia

  • A Ignaszewski, MD · St. Paul's Hospital, Vancouver, British Columbia

  • C Kerr, MD · St. Paul's Hospital, Vancouver, British Columbia

  • S Tung, MD · St. Paul's Hospital, Vancouver, British Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01248702 on ClinicalTrials.gov